Pfizer Headed for New High After FDA Nod for Joint Disease Treatment





Pfizer Headed for New High After FDA Nod for Joint Disease TreatmentShares of Pfizer appeared to be headed for a new high after the company announced that the FDA had approved its treatment for adult patients with active psoriatic arthritis.


READ MORE